openPR Logo
Press release

New Study: Global Outlook for Molecular Diagnostics and NAT Market Forecast to 2021

11-10-2017 07:18 AM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
New Study: Global Outlook for Molecular Diagnostics and NAT

Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients.

Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.

Request for Report TOC @ https://www.persistencemarketresearch.com/toc/5291

The market of molecular diagnostics is segmented on the basis of technology used in the diagnostic purposes, such as, amplification technologies, amplified gene detection technologies, DNA and oligonucleotide microarrays, and gene sequencing. Amplification technologies further segmented into multiple displacement amplification, ligase chain reaction, bio-barcode amplification assay, nucleic acid sequence based amplification, branched DNA and others. DNA microarrays are sub-segmented into array comparative genomic hybridization. Gene sequencing technique is divided into next generation sequencing and Sanger sequencing, whereas amplified gene detection technique is divided into microplate based flow cytometry and high resolution melting analysis. Further, the market is segmented on the basis of applications in the diagnosis of various diagnosis, such as, HIV diagnosis, influenza virus detection, hepatitis virus detection (hepatitis B and hepatitis C), STD testing, tuberculosis (Tb), Chlamydia testing, herpes simplex virus diagnosis, HPV, and many others. Moreover, molecular diagnostic tests are also applicable in the case of cancer, prenatal testing and disease risk management. The market for NAT is divided on the basis of various nucleic acid tests, such as, ligase chain reaction, reverse transcriptase PCR, quantiplex bDNA tests and others.

Moreover, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.

The market is driven by various growth propellers, such as, increased prevalence of infectious diseases, extensive R&D in diagnostic and medical imaging field, development of advanced diagnosis equipment due to technological growth and increased demand for sophisticated diagnostic tests by patients and healthcare professionals. Increased prevalence of chronic infectious diseases is one of the most prominent drivers of the market growth. According to WHO, AIDS is the world’s first deadliest disease. As of 2012, around 35.5 million people of the world suffers from AIDS and in 2012, AIDS killed around 1.6 million people.

Further, technological innovations are another market driver. Due to development of various technologically sound devices, the reliability of tests has been increased and it fuels the market growth. On the other hand, major growth hurdles include technological limitations and lack of awareness in certain region of the world and high costs associated with testing and equipment maintenance. Major opportunities include the development of cost-effective and hyper-accurate diagnostic tests and equipment, accomplished by awareness campaigns across the globe.

Request for Report Sample @ https://www.persistencemarketresearch.com/samples/5291

Major players operating in this market include Roche Diagnostics, Inc., Abbott Diagnostics Care, Becton, Dickinson and Company, GenMark Dx, Siemens Healthcare, AutoGenomics and others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Study: Global Outlook for Molecular Diagnostics and NAT Market Forecast to 2021 here

News-ID: 810373 • Views: 185

More Releases from Persistence Market Research

Digitized Healthcare To Revolutionize The E-Prescribing Market At A CAGR Of 23.5 …
According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3087 Electronic prescribing or E-Prescribing
Global COVID-19 Saliva-based Screening Market Share, Supply, Analysis and Foreca …
As per Persistence Market Research's latest industry analysis, the global COVID-19 saliva-based screening market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a declining CAGR of -3% over the forecast period of 2022 to 2031. COVID-19 saliva-based screening is attaining traction in the existing situation, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. COVID-19 saliva-based screening plays a dynamic role
Repositioning and Offloading Devices Market 2022 Global Significant Growth, Tech …
As per Persistence Market Research's latest revised industry analysis, the global repositioning and offloading devices market was valued at US$ 8.9 Bn in 2020, and is expected to exhibit a CAGR of close to 6% over the forecast period (2021-2031) Patient repositioning and offloading is one of the important methods to change a patient's position to avoid the risk of pressure ulcers. However, pressure ulcers is one of the common challenging
Packaging Additives Market is Estimated to Expanding at a Notable 4.3% CAGR Over …
Significant growth in global market of packaging additives can also be attributed to the contributions of North America and its developed nations such as the U.S. and Canada. North America is estimated to account for more than 21.9% of the revenue of global packaging additives market in 2018. In addition, the U.S. packaging additives market has witnessed substantial growth in the past few years which is likely to remain at

All 5 Releases


More Releases for NAT

Molecular Blood Typing, Grouping and Infectious Disease NAT Market Intelligence …
The global market for molecular blood typing, grouping and infectious disease nucleic acid testing (NAT) is increasing significantly. The market has huge scope due to growing demand for blood transfusion across the world. For the purpose of transfusion, donor blood compatibility with recipient patient is highly important. Thus, before transfusion of blood, in order to check compatibility, blood samples are cross-matched with each other. Transfusion of blood is usually safe,
Molecular Diagnostics and NAT Market Rugged Expansion Foreseen by 2021
The market is driven by various growth propellers, such as, increased prevalence of infectious diseases, extensive R&D in diagnostic and medical imaging field, development of advanced diagnosis equipment due to technological growth and increased demand for sophisticated diagnostic tests by patients and healthcare professionals. Increased prevalence of chronic infectious diseases is one of the most prominent drivers of the market growth. Molecular diagnostics is the application of medical and microbiological technologies
Molecular Diagnostics and NAT Market is Expected to Generate Huge Profits by 202 …
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the
Global Doctor Bags Market 2017 - Professional Case, Prestige, Pottertons, Elite …
Doctor Bags Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Scope of the Report: This report focuses on the Doctor Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Get Sample
Molecular Diagnostics and NAT Market is Expected to Gain Popularity Across the G …
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the
Nat-2 launches first ever 4 in 1 Sneaker
After the international, successful debut, fashion- and streetstyle-brand Nat-2 expands its innovative sneaker- and accessory-collection by adding new highlights. Company K&T GmbH, owner of brand Nat-2 presents after several years of development an international patented 2 in1 Sneaker, which turns into a beach-sandal by simply using the special-zipper, removing the upper from the Sandal. Target of the Nat-2 Team is to turn the shoe- and sneaker-industry upside down. To strengthen the